Better compliance to antihypertensive medications reduces cardiovascular risk
The DOI matches its Crossref record; 57 of the 59 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The effect of compliance with antihypertensive medications on the risk of cardiovascular outcomes in a population without a known history of cardiovascular disease has been addressed by a large population-based prospective, cohort study carried out by linking Italian administrative databases. METHODS: The cohort of 242 594 patients aged 18 years or older, residents in the Italian Lombardy Region, who were newly treated for hypertension during 2000-2001, was followed from index prescription until 2007. During this period patients who experienced a hospitalization for coronary or cerebrovascular disease were identified (outcome). Exposure to antihypertensive drugs from index prescription until the date of hospitalization or censoring was assessed. Proportional hazards models were fitted to assess the association between persistence on and adherence with antihypertensive drug therapy and outcome. Data were adjusted for several covariates. RESULTS: During an average follow-up of 6 years, 12 016 members of the cohort experienced the outcome. Compared with patients who experienced at least one episode of treatment discontinuation, those who continued treatment had a 37% reduced risk of cardiovascular outcomes (95% confidence interval 34-40%). Compared with patients who had very low drug coverage (proportion of days covered ≤ 25%), those at intermediate (from 51 to 75%) and high coverage (>75%) had risk reductions of 20% (16-24%) and 25% (20-29%), respectively. Similar effects were observed when coronary and cerebrovascular events were considered separately. CONCLUSIONS: In the real life setting, fulfillment compliance with antihypertensive medications is effective in the primary prevention of cardiovascular outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonadherence to antihypertensive treatment affects 10%-80% of hypertensive patients and is one of the key drivers of suboptimal BP control. 75-77”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [77]
In the citing paper
“and it is associated with an increased risk of cardiovascular events [45].”
Citations
Cites
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Self-citationDiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177
Selected major risk factors and global and regional burden of disease
Ezzati, M., Lopez, A. D., Rodgers, A., Vander Hoorn, S., & Murray, C. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11403-6 · Cited by 3,594
Law, M. R., Morris, J. K., & Wald, N. J. (2009) · BMJ · doi:10.1136/bmj.b1665 · Cited by 2,775
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,263
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis
Robin DiMatteo, M., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002) · Medical Care · doi:10.1097/00005650-200209000-00009 · Cited by 1,490
Worldwide prevalence of hypertension: a systematic review
Kearney, P. M., Whelton, M., Reynolds, K., Whelton, P. K., & He, J. (2004) · Journal of Hypertension · doi:10.1097/00004872-200401000-00003 · Cited by 1,140
Cited by
Items 301–365 of 365
Drug Adherence in Resistant Hypertension
Hamdidouche, I., Jullien, V., Laurent, S., & Azizi, M. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-76593-8_14
General discussion and future perspective
Tan, L. C. (2018) · CRC Press eBooks · doi:10.1201/9780429448676-9
Burning issues in blood pressure control
Ker, J. A., & Outhoff, K. (2019) · South African Family Practice · doi:10.4102/safp.v61i2.4986
How to recognize a non-adherent chronic heart failure patient?
Pelouch, R., Voříšek, V., Furmanová, V., & Solař, M. (2019) · Intervenční a akutní kardiologie · doi:10.36290/kar.2019.033
“práci byl zaznamenán trend k častější NA u žen (p = 0,055), ale závěry studií hodnotících vliv pohlaví na A k léčbě arteriální hypertenze (13, 29, 30) i CHSS (31, 32) nejsou jednoznačné.”
Burning issues in blood pressure control
Ker, J. A., & Outhoff, K. (2020) · South African General Practitioner · doi:10.36303/sagp.2020.3.0023
Zhussupova, G. (2020) · Journal of Health Development · doi:10.32921/2225-9929-2020-2-37-43-59 · Cited by 1
Prospects for the Development of Medical Tourism in the Republic of Kazakhstan
Seisenbek, G., Agibaeva, D., & Amanbekov, A. (2020) · Journal of Health Development · doi:10.32921/2225-9929-2020-2-37-60-66 · Cited by 1
Begesheva, D. (2020) · Journal of Health Development · doi:10.32921/2225-9929-2020-2-37-20-30
Persu, A. (2021) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2020.12.004
Szalay, T., Ištokovičová, P., Mužik, R., Knapčoková, V., & Benková, B. (2021) · Research Square · doi:10.21203/rs.3.rs-716374/v1
Fendt, A. (2010) · University of Vienna · doi:10.25365/thesis.10210
L’adhésion thérapeutique dans l’hypertension artérielle résistante
Huart, J., & Persu, A. (2022) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/j.amcp.2022.02.004
Joho, A. A., & Leshabari, S. (2019) · Research Square · doi:10.21203/rs.2.15277/v1
INVITED COMMENT: New NICE Guideline opts for stability
(2020) · Hypertension News · doi:10.30824/2003-10
Jamil, A., Kalmakhanov, S. B., Laura, S., Ainur, T., Daniyar, T., Бексеитович, П. С., & Кеmelbekov, К. (2022) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_689_20
Advances on Long-Term Antihypertensive Treatment and Diabetes
Chalmers, J. P., & Wang, N. (2023) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-13009-0_21
9th Asian Preventive Cardiology and Cardiac Rehabilitation Conference Symposia
Chai, C. C., Leong, B. K., Liew, L. K., Chow, K. C., & Kevin Wong Wu, K. (2023) · Journal of the Hong Kong College of Cardiology · doi:10.55503/2790-6744.1499
Garner, D. M., Wang, S., Raghu, A. L. B., Valenti, V. E., Aziz, T. Z., & Green, A. L. (2023) · Chaos Theory and Applications · doi:10.51537/chaos.1262839
Medication Adherence: Focus on Improvement
Haff, N., & Choudhry, N. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00031-1 · Cited by 1
Medication Compliance and Persistence: Doctors Prescribe; Patients Decide What to Do
Cramer, J. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00069-5
Adhésion aux traitements antihypertenseurs
Lelong, H. (2024) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/j.amcp.2024.02.015
Blood pressure control in the hypertensive population. Factors involved and perspectives
Mancia, G., Rea, F., & Corrao, G. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.06.021
Self-citationКонради, А. О. (2024) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2024-2454
Levin, J. B., Moore, D. J., Briggs, F. B. S., Rahman, M., Montoya, J. L., Depp, C. A., Einstadter, D., Stange, K. C., Weise, C., Maniglia, T., et al. (2024) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174241281984
Recent Advances in Therapeutic Approach for Hypertension to Improve Cardiac Health
Akhter, M. S., & Ahmad, Q. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.111841 · Cited by 3
van der Giet, M. (2024) · Nephrologie aktuell · doi:10.1055/a-2378-8811
Revolutionizing the Facilities Sector Innovations, Challenges, and Future Perspectives
(2024) · Contemporaneity of English Language and Literature in the Robotized Millennium · doi:10.46632/cellrm/3/1/4
Lee, B., Kim, B., Park, J. H., Chung, J., Park, C. G., Kim, J. W., Kim, Y. D., Park, W.-J., Kim, S., Cha, J., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020308
McEvoy, J. W., McCarthy, C. P., Brouwers, S., & Others, A. (2025) · HYPERTENSION · doi:10.22141/2224-1485.17.4.2024.372 · Cited by 2
Leow, A. S., Sule, A. A., Tay, J. C., Teong, H. H., Moy, W. L., Handa, P. K., Wu, Y. T., Chadachan, V. M., Oh, V. M. S., Sia, C., et al. (2025) · Singapore Medical Journal · doi:10.4103/singaporemedj.smj-2025-094 · Cited by 1
“[44,45] In addition to single-pill combinations, ESC also recommends the objective evaluation of adherence (either directly observed treatment or detecting the prescribed drugs in blood or urine sample).”
Jebali, S., Yakoubi, S., Amira, E., Ouni, M., & Galai, H. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5266687
Jebali, S., Yakoubi, S., Amira, E., Ouni, M., & Galai, H. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107239
Yimenu, D. K., Quek, H. W., Rafeld, P., Hareem, A., Gebreyohannes, E. A., Wang, K., Seubert, L., Lee, K., & Page, A. T. (2025) · International Journal of Pharmacy Practice · doi:10.1093/ijpp/riaf060 · Cited by 1
Čukanović, D., Jurisić, M., Todorović, N., Milijašević, D., Lalic-Popovic, M. N., Štrbac, D., & Milijašević, B. (2025) · Hospital Pharmacology - International Multidisciplinary Journal · doi:10.5937/hpimj2502655c
Tan, S. N. G., Muiruri, C., & González, J. M. (2025) · Medical Decision Making · doi:10.1177/0272989x251388046
Yang, J., Zeng, Y., Yang, L., Khan, N., Singh, S., Walker, R. L., Eastwood, R. L., & Quan, H. (2024) · Figshare · doi:10.6084/m9.figshare.26777332
Levin, J. B., Moore, D. J., Depp, C. A., Montoya, J. L., Briggs, F., Rahman, M., Stange, K. C., Einstadter, D., Weise, C., Conroy, C. M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20193408
Levin, J. B., Moore, D. J., Depp, C. A., Montoya, J. L., Briggs, F., Rahman, M., Stange, K. C., Einstadter, D., Weise, C., Conroy, C. M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20193414
Yang, J., Zeng, Y., Yang, L., Khan, N., Singh, S., Walker, R. L., Eastwood, R. L., & Quan, H. (2024) · Figshare · doi:10.6084/m9.figshare.26777335
Quaschning, K., Koerner, M., & Wirtz, M. A. (2022) · Figshare · doi:10.6084/m9.figshare.19695864
Sohn, I. S., Kim, C. J., Yoo, B.-S., Kim, B. J., Choi, J. W., Kim, D.-I., Lee, S.-H., Song, W.-H., Jeon, D. W., Cha, T. J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17210571
Morabito, G., Gregorio, C., Ieva, F., Barbati, G., Mancia, G., Corrao, G., & Rea, F. (2024) · Figshare · doi:10.6084/m9.figshare.26197421
Self-citationGalstyan, G. R., Dedov, I. I., Zolotukhin, I. A., Конради, А. О., Недошивин, А. О., Suchkov, I. A., Shestakova, M. V., & Shlyakhto, E. V. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6676
Savaré, L., Porcu, G., Tratsevich, A., Ronco, R., Ieva, F., & Corrao, G. (2026) · Osteoporosis International · doi:10.1007/s00198-025-07834-1
Self-citationMartins, E. D., Tavares, C. A. M., Favaro, L., Monfardini, F., Mourad, J., Khunti, K., Savarese, G., Berwanger, O., & Santo, K. (2026) · American Heart Journal · doi:10.1016/j.ahj.2026.107380
Most common mistakes in hypertension management
Seidlerová, J. (2026) · Vnitřní lékařství · doi:10.36290/vnl.2026.001
Galstyan, G. R., Dedov, I. I., Zolotukhin, I. A., Конради, А. О., Недошивин, А. О., Suchkov, I. A., Shestakova, M., & Shlyakhto, E. V. (2026) · Journal of Venous Disorders · doi:10.17116/flebo2026200116
Neufcourt, L. (2020) · theses.fr (ABES) · doi:10.70675/50ad929eza3c2z4124z8cabzc4233fc2911d · Cited by 1
Análisis de costoefectividad de la combinación fija de losartán más hidroclorotiazida en Colombia
Pico, L. F. Z., Benítez, P. F. G., & Hurtado, C. M. M. (2026) · Universitas Médica · doi:10.11144/javeriana.umed67.ceaf
Ojaimi, N., Beamer, B. A., Kheirbek, R., McArdle, P., Davies-Teye, B. B., Johnson, A., Alemi, F., & Kheirbek, R. (2026) · The Gerontologist · doi:10.1093/geront/gnag054
Butler, M. J., Lobosco, D., Miller, D., Honcharuk, E. M., Cheung, Y. K., & Goodwin, A. M. (2026) · Exploration of Medicine · doi:10.37349/emed.2026.1001402
McNally, R., Brett, S., & Olden, S. (2026) · Primary Health Care · doi:10.7748/phc.2026.e1890
Long‐Term Persistence and Treatment Changes of Antihypertensive Therapy: A 5‐Year Cohort Study
Asiri, A. A., Mubarik, S., Bos, J., Schuiling‐Veninga, C. C. M., Hak, E., & Taxis, K. (2026) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70286
Dong, L., Li, Y., Zhou, G., Fang, J., Jiang, J., Fan, F., Jia, J., Zhang, Y., Zheng, B., Zheng, Y., et al. (2026) · Digital Health · doi:10.1177/20552076261485113
Bech, J. N., McCormack, T., Bhalla, V., Ben-Dor, N., Segura, J., Christiansen, S. H., Andersen, I. T., Erhard, C., Rhodes, K. M., Norris, T., et al. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03771-5
Mancia, G., Brouwers, S., Calabria, S., Leogrande, M., Esposti, L. D., Desideri, G., & Narkiewicz, K. (2026) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvag073 · Cited by 1
Self-citation
Metadata
- Authors
- Corrao, G., Parodi, A., Nicotra, F., Zambon, A., Merlino, L., Cesana, G., & Mancia, G.
- Affiliations
- University of Milano-Bicocca (IT)
- University of Milan (IT)
- Regione Lombardia (IT)
- IRCCS Istituto Auxologico Italiano (IT)
- Corresponding author
- Corrao, Giovanni
- Venue
- Journal of Hypertension
- Published
- 2011-03
- Volume
- 29
- Issue
- 3
- Pages
- 610-618
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W1970957826
- Cited by
- 367
- References
- 59
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 33 · 2023: 26 · 2022: 26 · 2021: 35 · 2020: 33 · 2019: 33 · 2018: 29 · 2017: 22 · 2016: 17 · 2015: 18 · 2014: 25 · 2013: 21 · 2012: 10
- FWCI
- 11.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Funders
- Regione Lombardia
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Keywords
- antihypertensive medication adherence, hypertension, cardiovascular risk, cardiovascular hospitalization, coronary disease, cerebrovascular disease, primary prevention, treatment persistence, proportion of days covered
- MeSH terms
- Adult, Aged, Antihypertensive Agents, Cardiovascular Diseases, Female, Humans, Hypertension, Male, Middle Aged, Prospective Studies, Risk, Cohort Studies, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.